Family Medicine · St Clair Shores, MI
NPI
1659392496
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
23600 Harper Avenue, Suite 102
St Clair Shores, MI, 48080
Phone (586) 443-4940
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
748 services
Medicare patients, 2024
51
Average age 68
Drug cost, 2024
$157K
2,577 prescriptions
Company payments, 2025
$1,535
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajiv Agrawal was code 99213 (office e&m - established), 108 times for 39 patients. In total Rajiv Agrawal billed 748 services in 45 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 108 | 39 | $57.26 | $6,184 |
| 99214 Office E&M - Established | Office | 66 | 35 | $86.24 | $5,692 |
| 36415 Venipuncture Blood Collection | Office | 60 | 35 | $5.88 | $353 |
| 85025 Blood Count | Office | 56 | 31 | $7.61 | $426 |
| 84550 Clinical Chemistry | Office | 54 | 30 | $4.43 | $239 |
| 80053 Clinical Chemistry | Office | 54 | 30 | $10.35 | $559 |
| 84100 Clinical Chemistry | Office | 52 | 29 | $4.65 | $242 |
| 83735 Clinical Chemistry | Office | 52 | 29 | $6.57 | $342 |
| 83036 Blood Count | Office | 50 | 29 | $9.52 | $476 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 30 | 30 | $129.59 | $3,888 |
| 84443 Clinical Chemistry | Office | 23 | 22 | $16.46 | $379 |
| 82306 Clinical Chemistry | Office | 17 | 17 | $29.01 | $493 |
| 80061 Clinical Chemistry | Office | 17 | 17 | $13.12 | $223 |
By year: 2022 $29K for 1,059 services; 2023 $29K for 889 services; 2024 $23K for 748 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 60 | 35 | $5.88 | $353 |
| 85025 Blood Count | 56 | 31 | $7.61 | $426 |
| 84550 Clinical Chemistry | 54 | 30 | $4.43 | $239 |
| 80053 Clinical Chemistry | 54 | 30 | $10.35 | $559 |
| 84100 Clinical Chemistry | 52 | 29 | $4.65 | $242 |
| 83735 Clinical Chemistry | 52 | 29 | $6.57 | $342 |
| 83036 Blood Count | 50 | 29 | $9.52 | $476 |
| 84443 Clinical Chemistry | 23 | 22 | $16.46 | $379 |
| 80061 Clinical Chemistry | 17 | 17 | $13.12 | $223 |
| 82306 Clinical Chemistry | 17 | 17 | $29.01 | $493 |
Medicare prescription drug claims, 2024
In 2024, the drug Rajiv Agrawal prescribed most often to Medicare patients was Levothyroxine Sodium, with 132 prescriptions and refills. In total Rajiv Agrawal wrote 2,577 Medicare prescriptions that cost $157K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 132 | 353 | 33 | $1,577 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 130 | 136 | 17 | $1,850 |
| Amlodipine Besylate Generic | 103 | 230 | 28 | $568 |
| Alprazolam Generic | 99 | 105 | 15 | $412 |
| Losartan Potassium Generic | 92 | 223 | 25 | $1,210 |
| Atorvastatin Calcium Generic | 81 | 203 | 27 | $1,062 |
| Lisinopril Generic | 68 | 188 | 24 | $694 |
| Metformin Hcl Generic | 67 | 172 | 17 | $664 |
| Simvastatin Generic | 65 | 165 | 16 | $675 |
| Metoprolol Succinate Generic | 59 | 139 | 13 | $1,107 |
| Gabapentin Generic | 58 | 98 | 12 | $1,100 |
| Pantoprazole Sodium Generic | 57 | 103 | 12 | $728 |
| Omeprazole Generic | 45 | 109 | 17 | $649 |
| Zolpidem Tartrate Generic | 42 | 50 | Under 11 | $178 |
| Clopidogrel Clopidogrel Bisulfate | 42 | 100 | 11 | $497 |
Brand drugs: 246 claims; generic drugs: 2,304 claims; opioid claims: 179.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajiv Agrawal $1,535 ($1,535 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $382.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $382 |
| GlaxoSmithKline, LLC. GSK | 13 | $254 |
| Abbvie Inc. ABBV | 3 | $155 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $121 |
| Novo Nordisk Inc NVO | 6 | $111 |
| Abbott Laboratories ABT | 1 | $104 |
| Lilly USA, LLC LLY | 5 | $94.55 |
| Verona Pharma, Inc. VRNA | 5 | $89.08 |
| Amgen Inc. AMGN | 3 | $74.09 |
| Pfizer Inc. PFE | 2 | $36.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.